Xin Qi

Case Western Reserve University, Cleveland Heights, OH, United States 
Mitochondria, Neurodegeneration
"Xin Qi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ferreira JCB, Campos JC, Qvit N, et al. (2019) A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats. Nature Communications. 10: 329
Disatnik MH, Joshi AU, Saw NL, et al. (2016) Potential biomarkers to follow the progression and treatment response of Huntington's disease. The Journal of Experimental Medicine
Mochly-Rosen D, Disatnik MH, Qi X. (2014) The challenge in translating basic research discoveries to treatment of Huntington disease. Rare Diseases (Austin, Tex.). 2: e28637
Guo X, Disatnik MH, Monbureau M, et al. (2013) Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. The Journal of Clinical Investigation. 123: 5371-88
Disatnik MH, Ferreira JC, Campos JC, et al. (2013) Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. Journal of the American Heart Association. 2: e000461
Qi X, Qvit N, Su YC, et al. (2013) A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. Journal of Cell Science. 126: 789-802
Qi X, Disatnik MH, Shen N, et al. (2011) Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Molecular Biology of the Cell. 22: 256-65
Palaniyandi SS, Qi X, Yogalingam G, et al. (2010) Regulation of mitochondrial processes: a target for heart failure. Drug Discovery Today. Disease Mechanisms. 7: e95-e102
Qi X, Mochly-Rosen D. (2008) The PKCdelta -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis. Journal of Cell Science. 121: 804-13
Qi X, Inagaki K, Sobel RA, et al. (2008) Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. The Journal of Clinical Investigation. 118: 173-82
See more...